These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 36409765)

  • 41. Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.
    Zhu Y; Gu L; Lin X; Zhang J; Tang Y; Zhou X; Lu B; Lin X; Liu C; Prochownik EV; Li Y
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34914638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer.
    Stott KJ; Phillips B; Parry L; May S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34236075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered intestinal microbiota associated with colorectal cancer.
    Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
    Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.
    Zhang S; Kong C; Yang Y; Cai S; Li X; Cai G; Ma Y
    Theranostics; 2020; 10(25):11595-11606. PubMed ID: 33052235
    [No Abstract]   [Full Text] [Related]  

  • 47. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiome and colorectal adenomas.
    Dulal S; Keku TO
    Cancer J; 2014; 20(3):225-31. PubMed ID: 24855012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Power of the Gut Microbiome: Exploring New Perspectives in Colorectal Cancer Therapy].
    Takeda M; Doki Y
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):608-612. PubMed ID: 39009515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer.
    Mori G; Pasca MR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbial markers in colorectal cancer detection and/or prognosis.
    Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
    World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Gut Microbiome in Immune Regulation and Immune Checkpoint Therapy of Colorectal Cancer.
    Shi L; Xu Y; Feng M
    Dig Dis Sci; 2023 Feb; 68(2):370-379. PubMed ID: 36575326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
    Kong F; Cai Y
    Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer.
    Masheghati F; Asgharzadeh MR; Jafari A; Masoudi N; Maleki-Kakelar H
    Life Sci; 2024 May; 344():122529. PubMed ID: 38490297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.